Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study.
Saved in:
| Title: | Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study. |
|---|---|
| Authors: | Lopes MM; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.; Croce Clinic, São Paulo, São Paulo, Brazil., Castro APM; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.; Croce Clinic, São Paulo, São Paulo, Brazil., Ferrisse TM; School of Dentistry, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil., Kalil J; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil., Yang AC; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil., Castro FM; Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.; Croce Clinic, São Paulo, São Paulo, Brazil. |
| Source: | Drugs in context [Drugs Context] 2025 Jun 19; Vol. 14. Date of Electronic Publication: 2025 Jun 19 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Bioexcel Publishing Ltd Country of Publication: England NLM ID: 101262187 Publication Model: eCollection Cited Medium: Print ISSN: 1745-1981 (Print) Linking ISSN: 17404398 NLM ISO Abbreviation: Drugs Context Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
